Orbital decompression following treatment with teprotumumab for thyroid eye disease. Topilow NJ, Penteado RC, Ting M, Al-Sharif E, et al. Can J Ophthalmol 2024 Jul 23:S0008-4182(24)00174.

Read + Share

Amedeo Smart

Independent Medical Education

Topilow NJ, Penteado RC, Ting M, Al-Sharif E, et al. Orbital decompression following treatment with teprotumumab for thyroid eye disease. Can J Ophthalmol 2024 Jul 23:S0008-4182(24)00174.
PMID: 39059786